What are the side effects of immunotherapy for CLL

Side Effects of Immunotherapy for CLL

I'd be happy to explain the side effects associated with immunotherapy treatments for chronic lymphocytic leukemia (CLL). Let me break this down by the main types of immunotherapy used.

CAR T-Cell Therapy Side Effects

CAR T-cell therapy (such as lisocabtagene maraleucel) is one of the most important immunotherapy approaches for CLL. According to the NCCN Guidelines for CLL, the most common side effects include:

Most Frequent Side Effects:

• Cytokine Release Syndrome (CRS) — This occurs in about 85% of patients and happens when the immune cells release large amounts of inflammatory chemicals. Grade 3 or higher CRS (more severe) occurred in 9% of patients. Symptoms can include fever, chills, and fatigue.

• Neurologic events — These occurred in 45% of patients, with grade 3 or higher in 18%. Common neurologic side effects included:

  • Headache (29% of patients)
  • Confusion or confusional state (26%)
  • Dizziness (25%)

Blood Count Changes:

• Neutropenia (low white blood cells) — 60% of patients
• Anemia (low red blood cells) — 52% of patients
• Thrombocytopenia (low platelets) — 41% of patients

Other Important Side Effects:

• Infections — 17% experienced grade 3 or higher infections
• Second primary malignancies — Reported in 9% of patients (though none were related to the CAR T treatment itself)

How These Are Managed:

According to NCCN Guidelines, doctors manage CRS and neurologic toxicity using:

• Tocilizumab (a medication that reduces inflammation) — used in 67% of patients
• Corticosteroids — used in 33% of patients

Checkpoint Inhibitors (ICIs)

When checkpoint inhibitors like pembrolizumab or nivolumab are used for CLL (particularly for Richter transformation, a serious complication), the side effect profile can be different, though the NCCN Guidelines note that response rates have been variable and these are typically used in clinical trial settings.

Key Points to Remember:

✅ Most side effects are manageable — Your medical team has specific protocols to monitor and treat these complications

✅ Individual experiences vary — Not every patient experiences every side effect, and severity differs from person to person

✅ Close monitoring is essential — Regular blood work and clinical assessments help catch and manage side effects early

✅ Benefits often outweigh risks — For many CLL patients, CAR T-cell therapy can provide significant disease control

Questions to Ask Your Oncology Team:

1. Which specific immunotherapy are you recommending for me, and what are the most likely side effects I should watch for?

2. How will you monitor me for CRS and neurologic events, and how often will I have blood work?

3. What symptoms should I report immediately, and how do I reach your team if I develop concerning symptoms?

4. What support services are available if I experience side effects like confusion or severe fatigue?

5. Are there any clinical trials available that might be appropriate for my specific situation?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.